Evidence map›Paper›PMID 32442261›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010-2011 to 2016-2017.

Danuta M Skowronski, Macy Zou, Quinten Clarke, Catharine Chambers, James A Dickinson, Suzana Sabaiduc, Romy Olsha, Jonathan B Gubbay, Steven J Drews, Hugues Charest and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. HIV self-testing in Ottawa, Canada used by persons at risk for HIV: The GetaKit study.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2021
    Article
  11. Influenza vaccine during the 2019-2020 season and COVID-19 risk: A case-control study in Québec.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. 2020-2021 AMMI Canada guidance on the use of antiviral drugs for influenza in the setting of co-circulation of seasonal influenza and SARS-CoV-2 viruses in Canada.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2020
    Article
  17. The Need for Robust Epidemiological Evidence During a Pandemic.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  18. Article
  19. Article
  20. Selection bias may explain the relationship between coronavirus diagnosis and the odds of prior influenza vaccination.Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Danuta M SkowronskiBritish Columbia Centre for Disease Control, Vancouver, Canada.
Macy ZouBritish Columbia Centre for Disease Control, Vancouver, Canada.
Quinten ClarkeBritish Columbia Centre for Disease Control, Vancouver, Canada.
Catharine ChambersBritish Columbia Centre for Disease Control, Vancouver, Canada.
James A DickinsonUniversity of Calgary, Calgary, Canada.
Suzana SabaiducBritish Columbia Centre for Disease Control, Vancouver, Canada.
Romy OlshaPublic Health Ontario, Toronto, Canada.
Jonathan B GubbayPublic Health Ontario, Toronto, Canada.
Steven J DrewsProvincial Laboratory for Public Health, Edmonton, Canada.
Hugues CharestInstitut National de Santé Publique du Québec, Quebec City, Canada.
Anne-Luise WinterPublic Health Ontario, Toronto, Canada.
Agatha JassemBritish Columbia Centre for Disease Control, Vancouver, Canada.
Michelle MurtiPublic Health Ontario, Toronto, Canada.
Mel KrajdenBritish Columbia Centre for Disease Control, Vancouver, Canada.
Gaston De SerresInstitut National de Santé Publique du Québec, Quebec City, Canada.
BC Centre for Disease Control · CAPublic Health Ontario · CAUniversity of British Columbia · CACentre hospitalier universitaire de Québec · CAInstitut National de Santé Publique du Québec · CAUniversity of Alberta · CAUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza vaccine effectiveness against influenza and noninfluenza respiratory viruses (NIRVs) was assessed by test-negative design using historic datasets of the community-based Canadian Sentinel Practitioner Surveillance Network, spanning 2010-2011 to 2016-2017. Vaccine significantly reduced the risk of influenza illness by >40% with no effect on coronaviruses or other NIRV risk.

Indexed as

AdolescentAdultAgedCanadaCase-Control StudiesChildChild, PreschoolCoronavirus InfectionsFemaleHumansImmunogenicity, VaccineInfantInfluenza, HumanInfluenza VaccinesMaleMiddle AgedInfluenza Vaccinescoronavirusinfluenzanonspecific immunityrespiratory virusesvaccine effectiveness

Identifiers

PMID32442261
PMCPMC7314125
OpenAlexW3027855073

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.